Genetic characterization of advanced conjunctival melanoma and response to systemic treatment.

doi:10.1016/j.ejca.2022.01.008

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Genetic characterization of advanced conjunctival melanoma and response to systemic treatment.

European journal of cancer (Oxford, England : 1990) - 1 May 2022

Lodde Georg C, Jansen Philipp, Möller Inga, Sucker Antje, Hassel Jessica C, Forschner Andrea, Eckardt Julia, Meier Friedegund, Reinhardt Lydia, Kähler Katharina C, Ziemer Mirjana, Schlaak Max, Rahimi Farnaz, Schatton Kerstin, Meiss Frank, Gutzmer Ralf, Pföhler Claudia, Terheyden Patrick, Schilling Bastian, Sachse Michael, Heppt Markus V, Sindrilaru Anca, Leiter Ulrike, Zaremba Anne, Thielmann Carl M, Ugurel Selma, Zimmer Lisa, Hadaschik Eva, Bechrakis Nikolaos E, Schadendorf Dirk, Westekemper Henrike, Livingstone Elisabeth, Griewank Klaus G

Abstract excerpt

BACKGROUND: Conjunctival melanoma is a rare type of ocular melanoma, which is prone to local recurrence and metastasis and can lead to patient death. Novel therapeutic strategies have revolutionized cutaneous melanoma management. The efficacy of these therapies in conjunctival melanoma, however, has not been evaluated in larger patient cohorts. METHODS: In this multi-center retrospective cohort study with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Conjunctiva

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to Eye Neoplasms

Share to Immune Checkpoint Inhibitors

Share to Melanoma

Share to Melanoma, Cutaneous Malignant

Share to Mitogen-Activated Protein Kinase Kinases

Share to Skin Neoplasms

Source

Open in PubMed

Identifiers

PMID: 35279471
DOI: 10.1016/j.ejca.2022.01.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic characterization of advanced conjunctival melanoma and response to systemic treatment.PMID 35279471Read ↗

Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based TherapiesSemantic proximity Read ↗

Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma.Semantic proximity Read ↗

Genetic Aspects of Conjunctival Melanoma: A ReviewSemantic proximity Read ↗

Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes.Semantic proximity Read ↗

Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients.Semantic proximity Read ↗

Molecular, Genetic Susceptibility and Immunotherapy of MelanomaSemantic proximity Read ↗

Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.Semantic proximity Read ↗

Conjunctival Melanoma: Current Treatments and Future Options.Semantic proximity Read ↗

Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma PatientsSemantic proximity Read ↗

Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy PredictionSemantic proximity Read ↗

Integrative Exome and Transcriptome Analysis of Conjunctival Melanoma and Its Potential Application for Personalized TherapySemantic proximity Read ↗

NF1 mutations in conjunctival melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.